IL1B and inflammatory bowel disease: Of note, clinical evidence has documented an increase in IL-1β release from colonic tissues and macrophages of IBD patients, these patterns being correlated with disease severity, thus suggesting IL-1β as a relevant pro-inflammatory cytokine involved in the pathophysiology of IBDs (Coccia et al., 2012).